Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: A transcriptomic analysis

Experimental Gerontology

Volumn 48, Issue 3, 2013, Pages 305-312

  Kuparinen, Taru ^a,b   Marttila, Saara ^a,b   Jylhävä, Juulia ^a,b   Tserel, Liina ^c   Peterson, Pärt ^c   Jylhä, Marja ^a,b   Hervonen, Antti ^a,b   Hurme, Mikko ^a,b,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b Jyvaskyla University   (Finland)

^c UNIVERSITY OF TARTU   (Estonia)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cytomegalovirus; Immunosenescence; Nonagenarians; Pathway analysis; Transcriptomic analysis

Indexed keywords

MESSENGER RNA; RNA;

AGED; AGING; ARTICLE; CD8+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE; MICROARRAY ANALYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA ISOLATION; SEROLOGY; TRANSCRIPTOMICS;

ADULT; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84873288253     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.12.010     Document Type: Article

References (56)

1. Aberle J.H., Puchhammer-Stöckl E. Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults. Exp. Gerontol. 2012, 47:654-657.
2. Agarwal S., Busse P.J. Innate and adaptive immunosenescence. Ann. Allergy Asthma Immunol. 2010, 104:183-190.
3. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Würzner R., Schönitzer D., Grubeck-Loebenstein B. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 2005, 79:3675-3683.
4. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., Romagné F., Ugolini S., Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
5. Baracho G.V., Miletic A.V., Omori S.A., Cato M.H., Rickert R.C. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr. Opin. Immunol. 2011, 23:178-183.
6. Bartlett D.B., Firth C.M., Philips A.C., Moss P., Baylis D., Syddall H., Sayer A.A., Cooper C., Lord J.M. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012, 11:912-915.
7. Brown D.M. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell. Immunol. 2010, 262:89-95.
8. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001, 8:131-136.
9. Calder P.C. Omega-3 fatty acids and inflammatory processes. Nutrients 2010, 2:355-374.
10. Callahan J.E., Kappler J.W., Marrack P. Unexpected expansions of CD8-bearing cells in old mice. J. Immunol. 1993, 151:6657-6669.
11. Carlier J., Martin H., Mariamé B., Rauwel B., Mengelle C., Weclawiak H., Coaquette A., Vauchy C., Rohrlich P., Kamar N., Rostaing L., Herbein G., Davrinche C. Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood 2011, 118:6783-6792.
12. Clemmensen S.N., Bohr C.T., Rørvig S., Glenthøj A., Mora-Jensen H., Cramer E.P., Jacobsen L.C., Larsen M.T., Cowland J.B., Tanassi J.T., Heegaard N.H., Wren J.D., Silahtaroglu A.N., Borregaard N. Olfactomedin 4 defines a subset of human neutrophils. J. Leukoc. Biol. 2012, 91:495-500.
13. Collerton J., Martin-Ruiz C., Davies K., Hilkens C.M., Isaacs J., Kolenda C., Parker C., Dunn M., Catt M., Jagger C., von Zglinicki T., Kirkwood T.B.L. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mech. Ageing Dev. 2012, 133:456-466.
14. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 2006, 80:219-227.
15. Decman V., Laidlaw B.J., Doering T.A., Leng J., Ertl H.C., Goldstein D.R., Wherry E.J. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J. Immunol. 2012, 188:1933-1941.
16. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hähnel K., Slagboom P.E., de Craen A.J., Westenndorp R.G., Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185:4618-4624.
17. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., Longo D.L. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
18. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 2009, 21:38-46.
19. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutr. Rev. 2007, 65:S173-S176.
20. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
21. Fulop T., Larbi A., Witkowski J.M., McElhaney J., Loeb M., Mitnitski A., Pawelec G. Aging, frailty and age-related diseases. Biogerontology 2010, 11:547-563.
22. Goebeler S., Jylhä M., Hervonen A. Medical history, cognitive status and mobility at the age of 90. A population-based study in Tampere, Finland. Aging Clin. Exp. Res. 2003, 15:154-161.
23. Gomez C.R., Nomellini V., Faunce D.E., Kovacs E.J. Innate immunity and aging. Exp. Gerontol. 2008, 43:718-728.
24. Gumá M., Angulo A., Vilches C., Gómez-Lozano N., Malats N., López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
25. Hardie D.L., Baldwin M.J., Naylor A., Haworth O.J., Hou T.Z., Lax S., Curnow S.J., Willcox N., MacFadyen J., Isacke C.M., Buckley C.D. The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation. Immunology 2011, 133:288-295.
26. Hecker M., Qiu D., Marquardt K., Bein G., Hackstein H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 2004, 86:41-44.
27. Jackson S.E., Mason G.M., Wills M.R. Human cytomegalovirus immunity and immune evasion. Virus Res. 2011, 157:151-160.
28. Jonjić S., Pavić I., Polić B., Crnković I., Lućin P., Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 1994, 179:1713-1717.
29. Kallio M.A., Tuimala J.T., Hupponen T., Klemelä P., Gentile M., Scheinin I., Koski M., Käki J., Korpelainen E.I. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics 2011, 12:507.
30. Klenovsek K., Weisel F., Schneider A., Appelt U., Jonjic S., Messerle M., Bradel-Tretheway B., Winkler T.H., Mach M. Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007, 110:3472-3479.
31. Koch S., Larbi A., Özcelik D., Solana R., Gouttefangeas C., Attig S., Wikby A., Strindhall J., Franceschi C., Pawelec G. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann. N. Y. Acad. Sci. 2007, 1114:23-35.
32. Larbi A., Pawelec G., Wong S.C., Goldeck D., Tai J.J., Fulop T. Impact of age on T cell signaling: a general defect or specific alterations?. Ageing Res. Rev. 2011, 10:370-378.
33. Lazuardi L., Jenewein B., Wolf A.M., Pfister G., Tzankov A., Grubeck-Loebenstein B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005, 114:37-43.
34. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010, 147:35-51.
35. Mogensen T.H., Paludan S.R. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 2001, 65:131-150.
36. Mortensen L.H., Maier A.B., Slagbom P.E., Pawelec G., Derhovanessian E., Petersen I., Jahn G., Westendorp R.G.J., Christensen K. Early-life environment influencing susceptibility to cytomegalovirus infection: evidence from the Leiden Longevity Study and the Longitudinal Study of Aging Danish Twins. Epidemiol. Infect. 2012, 140:835-841.
37. Pawelec G. Immunity and ageing in man. Exp. Gerontol. 2006, 41:1239-1242.
38. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol. Rev. 2005, 205:257-268.
39. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19:47-56.
40. Pawelec G., Larbi A., Derhovanessian E. Senescence of the human immune system. J. Comp. Pathol. 2010, 142:S39-S44.
41. Roberts E.T., Haan M.N., Dowd J.B., Aiello A.E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly latinos over 9years of follow-up. Am. J. Epidemiol. 2009, 172:363-371.
42. Rölle A., Olweus J. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures. APMIS 2009, 117:413-426.
43. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E., Fagiolo U., Passeri M., Franceschi C. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993, 82:2767-2773.
44. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
45. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
46. Shaikh S.R. Diet-induced docosahexaenoic acid non-raft domains and lymphocyte function. Prostaglandins Leukot. Essent. Fat. Acids 2010, 82:159-164.
47. Sharif O., Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008, 213:701-713.
48. Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in United States. PLoS One 2011, 6:e16103.
49. Solana R., Tarazona R., Gayoso I., Lesur O., Dupuis G., Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin. Immunol. 2012, 24:331-341.
50. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301:380-382.
51. Tong C.Y., Bakran A., Williams H., Cuevas L.E., Peiris J.S., Hart C.A. Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J. Med. Virol. 2001, 64:29-34.
52. van Bergen J., Thompson A., Retière C., Trowsdale J., Koning K. Cutting edge: killer Ig-like receptors mediate "missing self" recognition in vivo. J. Immunol. 2009, 182:2569-2572.
53. Varani S., Frascaroli G., Landini M.P., Söderberg-Nauclér C. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity. Rev. Med. Virol. 2009, 19:131-145.
54. Vescovini R., Biasini C., Fagnoni F.F., Telera A.R., Zanlari L., Pedrazzoni M., Bucci L., Monti D., Medici M.C., Chezzi C., Franceschi C., Sansoni P. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J. Immunol. 2007, 179:4283-4291.
55. Wang G.C., Kao W.H.L., Murakami P., Xue Q.-L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., Fried L.P. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 2010, 171:1144-1152.
56. Wills M.R., Ashiru O., Reeves M.B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G.W., Sinclair J., Sissons J.G. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 2005, 175:7457-7465.